https://www.thebodypro.com/author/enid-vazquez

Latest by Enid Vazquez

Say Goodbye to 'Risk' Img
News

Say Goodbye to 'Risk'

Using the words "at risk" is risky in itself. It has the potential to turn people off -- and away from HIV prevention messages.

Promo Image

Treating Pneumonia in the Immunocompromised

The Centers for Disease Control and Prevention (CDC) reports on updated recommendations for the use of pneumonia vaccination in people who are immunocompromised, including people with HIV, in its October 12, 2012 Morbidity and Mortality Weekly Report...

Promo Image
African-Americans

African-American Women With HIV/HCV Less Likely to Die From Liver Disease

University of California San Francisco (UCSF) researchers have found that among women co-infected with HIV and hepatitis C virus (HCV), African Americans were less likely to die of liver disease. Of nearly 800 women enrolled in the Women's Interagenc...

Disclosure Among Teens Born Positive Img
News

Disclosure Among Teens Born Positive

"A study published by the Pediatric HIV/AIDS Cohort Study (PHACS) shows that, as with adults, disclosure of a positive HIV status to potential sex partners can be difficult for teenagers who were born HIV-positive," Enid Vázquez reports for _Positive...

Promo Image
News

Changes in Viramune XR Tablets for Kids

The FDA approved changes to the Viramune (nevirapine) Extended-Release (XR) tablet label to include the 100-mg tablet and dosing information for children ages six to 18 years. Previously, only 200-mg immediate release (IR) tablets or 400-mg extended ...

Black People Experience Less Viral Suppression Img
Conference Coverage

Black People Experience Less Viral Suppression

"Black people have less HIV virologic success (as shown by a drop in their viral load) than whites, according to a look at six gold-standard studies in HIV treatment with a total of nearly 5,000 individuals," Positively Aware reports.

Promo Image
Conference Coverage

Repeating Patterns: However, "Critical Consciousness" Can Break the Cycle of Abuse

Interview with Gwendolyn Kelso, M.A., and doctoral student on the study "Critical Consciousness, Perceived Racial Discrimination and Perceived Gender Discrimination in Relation to Demographics and HIV Status in African-American Women" at the 19th Int...

Promo Image
Neurocognitive

Sustiva, Atripla Tied to Neurologic Toxicity

A team of researchers from Johns Hopkins University School of Medicine reported that the way the body metabolizes the HIV medication efavirenz may contribute to cognitive (brain function-related) impairment. Efavirenz is sold under the brand name Sus...

Cure-Focused Research Grants Announced by amfAR Img
News

Cure-Focused Research Grants Announced by amfAR

Three new grants from the Foundation for AIDS Research (amfAR) have been awarded as part of the foundation's recent efforts to spur studies into HIV eradication. The grants will fund a range of studies seeking different paths toward a potential cure ...

Promo Image
Conference Coverage

Long-Acting Drug in Development

Chinese researchers presented proof-of-concept (in other words, "this can work") data on a long-acting HIV fusion inhibitor medication, which suppressed HIV for six to ten days after a single injection.

Currently, Fuzeon is the only fusion inhibitor...